Case Report: Blurred Vision and Eruptive Nevi - Bilateral Diffuse Uveal Melanocytic Proliferation With Mucocutaneous Involvement in a Lung Cancer Patient.

bilateral diffuse uveal melanocytic proliferation (BDUMP) melanoma non-small-cell lung cancer (NSCLC) plasmapheresis skin involvement

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2021
Historique:
received: 25 01 2021
accepted: 24 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

We describe a case of a 65-year old patient presenting with unusual mucocutaneous melanocytic proliferations of a Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) imitating a multifocal melanoma in situ, which improved dramatically after plasmapheresis. The patient first presented at the dermatology department due to rapidly evolving brown and black macules on the glans penis. Further skin involvement of the perineal and perianal region, mamillae and oral mucosa was stated. Histology from a penile biopsy was compatible with a melanoma in situ. Due to the distribution pattern and elevated serum tumor marker S100B, metastatic melanoma was considered. Staging examinations using PET-CT scan however, revealed a lung tumor, later confirmed as a Non-small-cell lung cancer (NSCLC). Primary radio chemotherapy was initiated to treat NSCLC. Shortly after initiation of radio chemotherapy the patient developed massive vision impairment and a NSCLC-associated BDUMP was diagnosed which led to the correct classification of melanocytic skin lesions as mucocutaneous BDUMP manifestation. Plasmapheresis was started resulting in a rapid improvement of vision starting ten days after the first plasmapheresis. In contrast skin manifestations started to disappear with a marked delay 4 months after the last plasmapheresis cycle. This case highlights the importance of memorizing multiple rapidly progressing melanocytic skin and/or mucous membrane spots together with visual impairment as a possible paraneoplastic BDUMP that needs a fundamentally different therapeutic approach compared to multifocal melanoma in situ. What is already known about this topic? Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) is a paraneoplastic syndrome with melanocytic uveal proliferation leading to vision impairment. Extraocular manifestation is rare, mainly affect the subepidermal compartment and is hard to treat. Plasmapheresis has been shown to be an effective treatment mainly for vision improvement in some but not all cases. What does this study add? Our BDUMP case with widespread skin and mucosal involvement initially mimicked a multifocal melanoma

Identifiants

pubmed: 33928039
doi: 10.3389/fonc.2021.658407
pmc: PMC8076566
doi:

Types de publication

Case Reports

Langues

eng

Pagination

658407

Informations de copyright

Copyright © 2021 Rafei-Shamsabadi, Schneider, Trefzer, Technau-Hafsi, Meiss and Ness.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eye (Lond). 2013 Sep;27(9):1058-62
pubmed: 23788206
Ophthalmologica. 1984;189(4):221-8
pubmed: 6096784
Retina. 2012 Oct;32(9):1959-66
pubmed: 22791177
J Clin Apher. 2011 Dec;26(6):356-61
pubmed: 21898575
Am J Ophthalmol. 2006 Oct;142(4):693-5
pubmed: 17011873
Br J Ophthalmol. 1991 Nov;75(11):693-5
pubmed: 1751469
Surv Ophthalmol. 2003 Nov-Dec;48(6):613-25
pubmed: 14609707
Arch Ophthalmol. 2011 Sep;129(9):1235-8
pubmed: 21911680
Pigment Cell Res. 2000 Feb;13(1):4-14
pubmed: 10761990
J Dermatol. 2015 Dec;42(12):1183-5
pubmed: 26077847
Br J Ophthalmol. 2015 Jul;99(7):943-8
pubmed: 25908835
Acta Ophthalmol. 2017 Aug;95(5):439-445
pubmed: 28636126
BMJ Case Rep. 2014 May 22;2014:
pubmed: 24855079
Int Urol Nephrol. 2016 Jan;48(1):133-8
pubmed: 26531062

Auteurs

David Rafei-Shamsabadi (D)

Department of Dermatology and Venereology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Johanna Schneider (J)

Department of Medicine IV, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Laura Trefzer (L)

Department of Dermatology and Venereology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Kristin Technau-Hafsi (K)

Department of Dermatology and Venereology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Frank Meiss (F)

Department of Dermatology and Venereology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Thomas Ness (T)

Eye Center, University Hospital Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Classifications MeSH